0001731038-24-000001.txt : 20240319 0001731038-24-000001.hdr.sgml : 20240319 20240319125935 ACCESSION NUMBER: 0001731038-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 EFFECTIVENESS DATE: 20240319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lindy Biosciences, Inc. CENTRAL INDEX KEY: 0001731038 ORGANIZATION NAME: IRS NUMBER: 815178025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-508013 FILM NUMBER: 24761890 BUSINESS ADDRESS: STREET 1: 100 CAPITOLA DRIVE STREET 2: SUITE 275 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-748-4480 MAIL ADDRESS: STREET 1: 100 CAPITOLA DRIVE STREET 2: SUITE 275 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Lindy Biosciences, LLC DATE OF NAME CHANGE: 20180212 D 1 primary_doc.xml X0708 D LIVE 0001731038 Lindy Biosciences, Inc. 627 Davis Drive Suite 400 Morrisville NC NORTH CAROLINA 27560 919-765-8700 DELAWARE Lindy Biosciences, LLC Corporation true Deborah Bitterfield 627 Davis Drive Suite 400 Morrisville NC NORTH CAROLINA 27560 Executive Officer Director Promoter Karen LeVert 627 Davis Drive Suite 400 Morrisville NC NORTH CAROLINA 27560 Director Joel Whitley 627 Davis Drive Suite 400 Morrisville NC NORTH CAROLINA 27560 Director Omar Flores 627 Davis Drive Suite 400 Morrisville NC NORTH CAROLINA 27560 Executive Officer Director Biotechnology Decline to Disclose 06b false 2024-03-12 false true true false 0 2500000 1709637 790363 false 10 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers. false Lindy Biosciences, Inc. Deborah Bitterfield Deborah Bitterfield CEO 2024-03-19